New Stock Information | Kunlun New Energy Materials Files for Listing on the Hong Kong Stock Exchange
According to the disclosure by the Hong Kong Stock Exchange on January 28, Kunlun New Energy Materials Technology (Yichang) Co., Ltd. (referred to as Kunlun New Energy Materials) has submitted its listing application to the main board of the Hong Kong Stock Exchange. CITIC Securities International and Ping An Securities (Hong Kong) are its joint sponsors.
According to the disclosure by the Hong Kong Stock Exchange on January 28, Kunlun New Energy Materials Technology (Yichang) Co., Ltd. (referred to as "Kunlun New Energy Materials") has submitted its listing application to the main board of the Hong Kong Stock Exchange. China Securities Co., Ltd. International and Ping An Securities (Hong Kong) are its joint sponsors. The company has become a rapidly growing electrolyte technology enterprise in China, with its market share steadily increasing in recent years. According to Frost & Sullivan data, based on shipment volume, the company ranked third among global electrolyte suppliers for the nine months ending September 30, 2025. In addition, the company has strategically positioned itself in the field of advanced battery materials such as solid-state electrolytes (SSE), gel electrolytes, solid-liquid hybrid electrolytes, and sodium-ion electrolytes.
According to the prospectus, the company is a global leading supplier of lithium battery electrolytes, focusing on the research, development, production, and sales of lithium battery electrolytes and advanced battery materials. With technological advantages and production capacity supported by strategic layout, the company provides stable, safe, efficient, and advanced products for the global new energy industry.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


